Drug Database
Back to search

Czechia· CZ-0209433

QTERN

A saxagliptin and dapagliflozin product containing saxagliptine hydrochloride + dapagliflozin propylene glycol monohydrate, registered in Czechia by AstraZeneca AB, Södertälje. The same ATC class is registered in 11 of our 19 countries.

ATC A10BD21

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedQTERNATCA10BD21REGISTER NO.CZ-0209433PACKS LISTED0CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about saxagliptine hydrochloride + dapagliflozin propylene glycol monohydrateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Saxagliptin and dapagliflozin is registered in 11 of 19 countries.

Countries holding a registration under ATC A10BD21 (saxagliptin and dapagliflozin), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 7 of them publish a price we can compare per daily dose
Search saxagliptin and dapagliflozin products by name

Saxagliptin and dapagliflozin · ATC A10BD21

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
SAXAGLIPTINE HYDROCHLORIDE + DAPAGLIFLOZIN PROPYLENE GLYCOL MONOHYDRATE
Manufacturer
AstraZeneca AB, Södertälje
Country
Czechia (CZ)
ATC code
A10BD21
ATC class
Saxagliptin and dapagliflozin
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Saxagliptin and dapagliflozin in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All saxagliptin and dapagliflozin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ef7b0754-9c60-4923-a2ce-91343db4d53d
GET /v1/drugs/ef7b0754-9c60-4923-a2ce-91343db4d53d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "TBL FLM",
  "source": "sukl",
  "strength": "5MG/10MG",
  "pack_size": "30",
  "substance": "SAXAGLIPTINE HYDROCHLORIDE + DAPAGLIFLOZIN PROPYLENE GLYCOL MONOHYDRATE",
  "cz_kod_sukl": "0209433",
  "product_type": "CH",
  "substance_codes": "18705,19747",
  "registration_state": "R",
  "registration_number": "EU/1/16/1108/004"
}
API referenceMCP serverPlans

See everything about saxagliptin and dapagliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console